1. 1) Steinberg, D.; Parthasarathy, S.; Carew, T.E.; Khoo, J.C.; Witztum, J.L. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 320, 915-924 (1989).
2. 2) Kinoshita, M.; Oikawa, S.; Hayasaka, K.; Sekikawa, A.; Nagashima, T.; Toyota, T.; Miyazawa, T. Age-related increases in plasma phosphatidylcholine hydroperoxide concentrations in control subjects and patients with hyperlipidemia. Clin. Chem. 46, 822-828 (2000).
3. 3) Kiko, T.; Nakagawa, K.; Tsuduki, T.; Suzuki, T.; Arai, H.; Miyazawa, T. Significance of lutein in red blood cells of Alzheimer’s disease patients. J. Alzheimer’s Dis. 28, 593-600 (2012).
4. 4) Kiko, T.; Nakagawa, K.; Satoh, A.; Tsuduki, T.; Furukawa, K.; Arai, H.; Miyazawa, T. Amyloid beta levels in human red blood cells. PLoS One 7, e49620 (2012).
5. 5) Nagashima, T.; Oikawa, S.; Hirayama, Y.; Tokita, Y.; Sekikawa, A.; Ishigaki, Y.; Yamada, R.; Miyazawa, T. Increase of serum phosphatidylcholine hydroperoxide dependent on glycemic control in type 2 diabetic patients. Diabetes Res. Clin. Pract. 56, 19-25 (2002).